Ennio Cavalletti

1.8k total citations
35 papers, 1.5k citations indexed

About

Ennio Cavalletti is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Ennio Cavalletti has authored 35 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Molecular Biology and 5 papers in Organic Chemistry. Recurrent topics in Ennio Cavalletti's work include Cancer Treatment and Pharmacology (7 papers), Synthesis and biological activity (4 papers) and Chemotherapy-induced organ toxicity mitigation (4 papers). Ennio Cavalletti is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), Synthesis and biological activity (4 papers) and Chemotherapy-induced organ toxicity mitigation (4 papers). Ennio Cavalletti collaborates with scholars based in Italy, United States and Netherlands. Ennio Cavalletti's co-authors include N Oggioni, Guido Cavaletti, G Tredici, O. Tofanetti, Maurizio D’Incalci, F. Sala, Franco Zunino, Graziella Pratesi, Gabriella Pezzoni and Luca Crippa and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Journal of Hepatology.

In The Last Decade

Ennio Cavalletti

35 papers receiving 1.4k citations

Peers

Ennio Cavalletti
Ennio Cavalletti
Citations per year, relative to Ennio Cavalletti Ennio Cavalletti (= 1×) peers Patrizia Cristofori

Countries citing papers authored by Ennio Cavalletti

Since Specialization
Citations

This map shows the geographic impact of Ennio Cavalletti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ennio Cavalletti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ennio Cavalletti more than expected).

Fields of papers citing papers by Ennio Cavalletti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ennio Cavalletti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ennio Cavalletti. The network helps show where Ennio Cavalletti may publish in the future.

Co-authorship network of co-authors of Ennio Cavalletti

This figure shows the co-authorship network connecting the top 25 collaborators of Ennio Cavalletti. A scholar is included among the top collaborators of Ennio Cavalletti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ennio Cavalletti. Ennio Cavalletti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bello, Ezia, Giulia Taraboletti, Gennaro Colella, et al.. (2012). The Tyrosine Kinase Inhibitor E-3810 Combined with Paclitaxel Inhibits the Growth of Advanced-Stage Triple-Negative Breast Cancer Xenografts. Molecular Cancer Therapeutics. 12(2). 131–140. 39 indexed citations
2.
Bello, Ezia, Gennaro Colella, Paolo Oliva, et al.. (2011). E-3810 Is a Potent Dual Inhibitor of VEGFR and FGFR that Exerts Antitumor Activity in Multiple Preclinical Models. Cancer Research. 71(4). 1396–1405. 117 indexed citations
4.
Cozza, Giorgio, Andrea Bortolato, Ernesto Menta, et al.. (2009). ATP Non-Competitive Ser/Thr Kinase Inhibitors as Potential Anticancer Agents. Anti-Cancer Agents in Medicinal Chemistry. 9(7). 778–786. 10 indexed citations
5.
Cavalletti, Ennio, et al.. (2007). Pixantrone (BBR 2778) has reduced cardiotoxic potential in mice pretreated with doxorubicin: Comparative studies against doxorubicin and mitoxantrone. Investigational New Drugs. 25(3). 187–195. 56 indexed citations
6.
Mazzanti, Benedetta, Tiziana Biagioli, Alessandra Aldinucci, et al.. (2005). Effects of pixantrone on immune-cell function in the course of acute rat experimental allergic encephalomyelitis. Journal of Neuroimmunology. 168(1-2). 111–117. 7 indexed citations
7.
Cavaletti, Guido, N Oggioni, F. Sala, et al.. (2000). Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study. Toxicology Letters. 118(1-2). 103–107. 49 indexed citations
8.
Manzotti, C., Graziella Pratesi, E. MENTA, et al.. (2000). BBR 3464: a novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatin.. PubMed. 6(7). 2626–34. 154 indexed citations
9.
Cavaletti, Guido, Ennio Cavalletti, N Oggioni, et al.. (2000). Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration.. PubMed. 21(3). 389–93. 141 indexed citations
10.
Cavalletti, Ennio, Guido Cavaletti, G Tredici, et al.. (1999). Oral and intravenous BNP7787 protects against paclitaxel-mediated neurotoxicity in Wistar rats. 40. 398. 6 indexed citations
11.
Scanziani, Eugenio, Alberto Gobbi, Luca Crippa, et al.. (1998). Hyperkeratosis-associated coryneform infection in severe combined immunodeficient mice. Laboratory Animals. 32(3). 330–336. 24 indexed citations
12.
Cavalletti, Ennio, et al.. (1996). Comparative toxicology of two enantiomers of the peripherally acting non-narcotic antitussive drug moguisteine.. PubMed. 46(12). 1114–9. 1 indexed citations
13.
Scanziani, Eugenio, Luca Crippa, Anna Maria Giusti, et al.. (1995). Leptospira interrogans serovar sejroe infection in a group of laboratory dogs. Laboratory Animals. 29(3). 300–306. 18 indexed citations
14.
Melloni, E., et al.. (1994). Acute intravenous toxicity of dimethyl sulfoxide, polyethylene glycol 400, dimethylformamide, absolute ethanol, and benzyl alcohol in inbred mouse strains.. PubMed. 44(4). 566–70. 66 indexed citations
15.
Cignarella, Giorgio, Daniela Barlocco, Gérard A. Pinna, et al.. (1989). Synthesis and biological evaluation of substituted benzo[h]cinnolinones and 3H-benzo[6,7]cyclohepta[1,2-c]pyridazinones: higher homologs of the antihypertensive and antithrombotic 5H-indeno[1,2-c]pyridazinones. Journal of Medicinal Chemistry. 32(10). 2277–2282. 30 indexed citations
16.
Zunino, Franco, et al.. (1989). Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug. Chemico-Biological Interactions. 70(1-2). 89–101. 144 indexed citations
17.
Barlocco, Daniela, et al.. (1988). Synthesis and pharmacological study of 5-aryl-6-methyl-4,5-dihydro-pyridazin-3(2H)ones and related 5-aryl-6-methyl-pyridazin-3(2H)ones.. PubMed. 43(6). 539–49. 2 indexed citations
18.
Tofanetti, O., et al.. (1985). Prevention of cyclophosphamide-induced urotoxicity by reduced glutathione and its effect on acute toxicity and antitumor activity of the alkylating agent. Cancer Chemotherapy and Pharmacology. 14(3). 188–93. 15 indexed citations
19.
Zunino, Franco, et al.. (1983). Protective Effect of Reduced Glutathione against CIS-Dichlorodiammine Platinum (II)–Induced Nephrotoxicity and Lethal Toxicity. Tumori Journal. 69(2). 105–111. 36 indexed citations
20.
Cavalletti, Ennio, et al.. (1980). Bovine paramphistomiasis in the province of Milan. Clinical and epizootiological investigations.. 103(5). 284–296. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026